Novo Nordisk A/S (ADR)(NYSE:NVO) will take part in honoring the hemophilia community. The company has opened a Facebook Inc (NASDAQ:FB) page dubbed Changing Hemophilia. Every visitor to the page will be allowed to nominate a person who has demonstrated courage and extraordinary effort in their acts to help knock down barriers to unity.
The visitors can include a classified message of their hemophilia hero describing why or what led them into highlighting that particular person.
According to Novo Nordisk, every bit of their effort is worth it in taking the community to the next level. The company will honor these heroes by featuring submitted stories and photos on the ‘Changing Hemophilia Facebook page.’ In addition, it will provide continued patient- and caregiver-focused programs through a #HemoHero initiative.
Novo Nordisk’s VP Biopharmaceuticals Portfolio, Bill Breitenbach says, “Each person in the hemophilia community has a hero who inspires them ……. or caring for someone with a chronic condition and to be proud of their own accomplishments.”
There are over 20,000 people in the United States suffering from Hemophilia, a rare genetic bleeding disorder. The condition primarily affects males but females can also bring and pass on the gene. More often than not, the disorder results in internal bleeding given that the blood does not clot normally.
However, Novo Nordisk will not just sit back and watch, them having a hemophilia portfolio after all. Through the #HemoHero initiative, the company will be sharing stories in this year’s World Hemophilia Day, which will carry the theme “Hear Their Voices.” The day tends to commemorate the resilience of these heroes who apparently live positively despite their life-long condition.
The global company’s initiatives will also involve life coaching and peer support to teens living with hemophilia through RareBleedingDisorders.com platform, which highlights updates from hemophilia medical meetings and conferences.
In the meantime, Novo Nordisk’s stock closed at $36.09 witnessing an increase of $0.34 or 0.95%.
